Author Question: Staff at a women's health center are being briefed by their supervisor on the latest recommendations ... (Read 111 times)

audie · **on:** Jun 25, 2018

Staff at a women's health center are being briefed by their supervisor on the latest recommendations for breast cancer screening. Which of the following guidelines should staff pass on to their clients?

A)
Breast self-exam should be ideally performed around the time of the month that you think you're ovulating.
B)
The most important thing you can do to identify breast cancer early is to perform regular, systematic self-exams.
C)
All postmenarche females should get a clinical exam by a trained professional on an annual basis.
D)
Screening mammography and clinical exams are the cornerstones of breast cancer screening.

Question 2

A 40-year-old African American patient is at increased risk of developing prostate cancer, since his father was diagnosed with the disease at age 60 and his brother at age 56.

What diagnostic measures should be undertaken?
A)
PSA and DRE starting before the age of 50
B)
Transrectal ultrasonography starting immediately
C)
PSA and DRE starting at age 50
D)
Transrectal MRI starting at age 45

kingfahad97 · **Reply #1 on:** Jun 25, 2018

Answer to Question 1

Ans:
D

Feedback:

Self-exam has recently been deemphasized by the American Cancer Society with emphasis now placed on mammography and trained exam. If done, self-exam should be performed around the time of menses, and clinical exams every 3 years are believed to be sufficient for women under 40.

Answer to Question 2

Ans:
A

Feedback:

The current recommendation of the American Cancer Society and the American Urological Association is that men at increased risk of prostate cancer, such as this patient, who has two risk factors, his race and his family history, should begin screening with an annual digital rectal exam (DRE) and prostate-specific antigen (PSA) measurement starting at age 45. The general population is advised to undergo this process starting at age 50. It is important to note that PSA levels can be a marker of either benign prostatic hyperplasia or cancer, and there is some degree of controversy regarding the benefit of screening for it. Although transrectal ultrasonography may detect small cancers, its prohibitive cost excludes its routine use in screening.